In recent years, much progress has been made in analyzing the molecular origin of many diseases in vivo. For most applications, attention has been devoted to the detection of single molecules only. In this study, we present a proof of concept for the straightforward monitoring of interactions between different molecules via Fö rster resonance energy transfer (FRET) in an in vivo spectral multiplexing approach using conventional small organic dyes covalently attached to antibodies. Methods: We coupled the fluorophores DY-682 (donor; absorption [abs]/ emission [em], 674/712 nm), DY-505 (control donor; abs/em, 498/529 nm), and DY-782 (acceptor; abs/em, 752/795 nm) to the model antibody IgG. The occurrence of FRET between these fluorophores was assessed in vitro for conjugate mixtures adsorbed onto membranes, after accumulation into the phagocytic compartment of macrophages (J774 cells), and in vivo in a mouse edema model using a whole-body animal imaging system with multispectral analysis features. Results: When the free acceptor DY-782 was combined with the DY-682 donor, FRET occurred as a consequence of small dye-to-dye distances, unlike the case for mixtures of the dyes DY-782 and DY-505. Our proof of concept was also transferred to living cells after internalization of the DY-682-IgG-DY-782-IgG pair into macrophages and finally to animals, where intermolecular FRET was observed after systemic probe application in vivo in edema-bearing mice. Conclusion: Our simple cooperative-imaging approach enables the noninvasive detection of the presence of two or principally even more neighboring disease-related biomarkers. This finding is of high relevance for the in vivo identification of complex biologic processes requiring strong spatial interrelations of target molecules in key pathologic activation processes such as inflammation, cancer, and neurodegenerative diseases.
Underst anding the molecular basis and function of diseases is known to be decisive for the identification of new drug targets and the recognition of new strategies for determining the diagnosis and prognosis early. Extensive research in this field has demonstrated the complexity of interactions that take place on the molecular level in the course of disease progression-interactions that involve alterations in the genome, transcription, processing of transcripts, transport, and product degradation, among others. This experience pioneered the development of in vivo imaging techniques at the molecular level to better identify defined disease states. Among them, optical imaging turned out to be a favorable modality, since it does not require ionizing radiation, is inexpensive, and comprises an easy-tooperate instrumentation providing high detection sensitivity and multiplexing capabilities. Different optical approaches have been considered so far. Bioluminescence imaging offers the possibility to study ongoing molecular processes by the use of genetically encoded luminescent proteins incorporated into cells or laboratory animals. However, these luminescent proteins do not enable deep tissue penetration; they are hampered by tissue-related absorption and lead to comparatively low tumor-to-background ratios due to a distinct signal contribution from tissue-related autofluorescence. Additionally, the incorporation of foreign genetic material lowers the clinical potential significantly. In contrast, optical probes with absorption and emission bands in the near-infrared region (650-900 nm) (1) enable a relatively deep tissue penetration due to reduced absorption by water and hemoglobin and yield an improved signal-to-noise ratio (2, 3) . Consequently, the clinical potential of near-infrared fluorescence (NIRF) imaging is considered to be high. So far, most in vivo NIRF optical imaging approaches have been based on the detection of informative biomarker expression target tissues only.
Förster resonance energy transfer (FRET) may offer the potential to image molecular cooperation representing key functional markers in disease, such as defined biochemical activation processes, providing more accurate insights into highly tuned and regulated disease processes. FRET is a phenomenon that takes place when 2 different chromophores (donor and acceptor) with overlapping emission/absorption spectra undergo long-range dipole-dipole coupling (3, 4) . Several interesting approaches have been reported from microscopic analysis in vitro (5) (6) (7) (8) and ultimately also in vivo (9) . In the latter case, mutants of green fluorescent protein (10, 11) with varying spectral properties have been used together with recombinant techniques to introduce those fused proteins containing the respective FRET donor and acceptor chromophores into cell systems.
With the aim of developing simple approaches toward multiplexed in vivo imaging of biomarker interrelations using a conventional animal imager for multispectral imaging, we describe here an in vivo intermolecular FRET approach that relies on probes in which donor and acceptor are bound to different biomacromolecules. This technique exploits 2 nearinfrared-absorbing and -emitting asymmetric cyanine dyes, each covalently attached to a model biomarker-specific ligand (antibody, IgG) because both probes can be condensed into endolysosomes of monocytes or macrophages via phagocytosis. As a first proof for our envisioned concept, we chose DY-682 and DY-782 antibody conjugates, with DY-682 acting as donor and DY-782 as acceptor of this potential FRET pair. The advantage of these near-infrared fluorophores lies in their higher fluorescence quantum yields, enhanced thermal stability, and reduced cytotoxicity in endothelial cells and macrophages compared with indocyanine green (12) (13) (14) (15) . The close proximity of both probes is expected to result in FRET. The enhancement of the fluorescence intensity of DY-782 is indicative of the simultaneous presence of both probes and thus, eventually, of 2 specific molecular structures in close proximity.
MATERIALS AND METHODS

Synthesis of NIRF Probes
For preparation of the fluorescent probes, polyclonal IgG from rabbit serum (Sigma-Aldrich GmbH) was used. N-hydroxysuccinimidyl esters of the fluorescent dyes DY-505, DY-682, and DY-782 were provided by Dyomics GmbH and coupled to IgG according to the manufacturer's instructions. Briefly, IgG antibodies (1 mg) were dissolved in 100 mM NaHCO 3 and 500 mM NaCl, pH 8.0. The dye, dissolved in dimethyl formamide at a concentration of 20 mg/mL, was added in a molecular weight ratio of 6:1 (dye:IgG). After incubation of the reaction mixture for 2 h at room temperature, the fluorescent probes were purified chromatographically. The labeling densities (dye-to-protein ratios) were calculated from the absorbance of the conjugate at 280 nm (corrected for dye contribution) and the integral absorbance at the dye's longest wavelength absorption band (16, 17) .
Spectroscopic Characterization of Near-Infrared Dyes
The absorption spectra were recorded on a Cary 5000 ultraviolet/visible light/near-infrared spectrophotometer (Varian Inc.) using 1-cm quartz cells. The fluorescence spectra were measured with a calibrated SLM 8100 spectrofluorometer (Spectronics Instruments) with Glan Thompson polarizers placed in the excitation and emission channels and set to 0°and 54.7°, respectively (18) . For the fluorescence measurements and determination of the fluorescence quantum yields, quartz cuvettes with an optical path length of 1 cm in the direction of the excitation light and 0.2 cm in the direction of the fluorescence were used. The fluorescence quantum yields were determined by following a previously described procedure (19) (20) . For semiquantitative analysis of probe fluorescence signatures, regions of interest (2,000-2,500 pixels) were determined using the spectrally unmixed image of the respective optical probe. Fluorescence signatures were calculated from averaged counts, each representing the area under the curve of the respective unmixed probe spectrum. Average counts were normalized to pixel number and exposure time.
In Vitro Imaging of Immobilized Probes on Protein Adsorbing (Western Blotting) Membranes
Non-and IgG-conjugated dyes were spotted onto Western blotting membranes (e.g., nitrocellulose; Amersham Biosciences) in amounts of up to 0.2 nmol for each dye (concentrations of up to 130 pmol/cm 2 for each dye, in spots containing donor and acceptor molecules). The dried membrane was imaged with the wholebody NIRF scanner. The images were processed and analyzed as described for whole-body imaging. To determine the optimal relationship between donor and acceptor molecules (IgG-conjugated probe components), different donor-to-acceptor amounts were studied. In previous experiments, a donor-to-acceptor stoichiometry of 1 to 1 was determined to be optimal for the occurrence of FRET. Average donor-to-acceptor distances were estimated on the basis of the calculated dye concentration per spotted area, assuming a homogeneous distribution of the dyes.
Cell Culture
J774 murine macrophages (DSMZ) were grown in Dulbecco modified Eagle medium (Invitrogen) containing fetal calf serum (Gibco BRL, 10% [v/v] ) at 37°C in a 5% CO 2 atmosphere.
In Vitro Imaging of Stained Macrophages
After cultivation of 5.5 · 10 5 J774 macrophages for 24 h, the probes or free dyes were added (5 mL, final dye concentration of 1.2 nmol/mL). The cells were cultured for a further 24 h and were then harvested by scraping and washed 3 times with phosphatebuffered saline. After centrifugation, the pellet was dissolved in 200 mL of cell culture medium and pictured with the Maestro. To verify dye uptake, cells were analyzed microscopically via confocal laser scanning microscopy.
Animal Experiments
All procedures were approved by the regional animal committee and were in accordance with international guidelines on the ethical use of animals. Male Naval Medical Research Institute (NMRI) mice were housed under standard conditions with food and water ad libitum. Starting 7-14 d before the experiments, all mice received a low-pheophorbide diet (C 1039; Altromin) to reduce autofluorescence. At the beginning of the experiments, all animals were shaved at the area intended for imaging (head or back).
In Vivo NIRF Imaging of Subcutaneously Injected Matrigel Cushions Bearing Probe-Stained Macrophages J774 macrophages (1.5 · 10 7 ) were incubated with a 1.2 nmol/mL concentration of IgG-DY-682 and IgG-DY-782 alone or in combination or remained unstained. Cell pellets were taken up in 100 mL of Matrigel (BD Bioscience) and injected subcutaneously on the back of a mouse, so that each mouse bore 4 Matrigel cushions. For controls, mice received the same treatment but with the IgG-DY-682 replaced by IgG-DY-505. Both the IgG-DY-682-IgG-DY-782 and the IgG-DY-505-IgG-DY-782 groups consisted of 3 animals. The mice were imaged, and the acquired spectral imaging data were analyzed.
In Vivo NIRF Imaging of Ear Edema in Mouse Model
Ear edema was induced in accordance with a protocol from Kurnatowska and Pawlikowski (21) . Twenty-eight male NMRI mice were divided into 7 groups consisting of 4 animals each. The different groups received the following treatments: untreated (group 1), only zymosan A injected (group 2), zymosan A injected and treated with IgG-DY-505 (group 3), IgG-DY-682 (group 4), IgG-DY-782 (group 5), IgG-DY-505 and IgG-DY-782 (group 6), or IgG-DY-682 and IgG-DY-782 (group 7). Edema was induced in all mice except the untreated native control group by injecting 20 mL of a 1% (w/v) suspension of zymosan A (Sigma-Aldrich GmbH) into the root of the left ear. Immediately afterward, equimolar amounts of probes were intravenously injected into the tail veins of the mice of corresponding groups (amount corresponding to 55 nmol of dye per kilogram of body weight). The mice were imaged, and the acquired spectral imaging data were analyzed. To verify dye uptake in target cells, the mice were euthanized and cells from the edematous region were isolated by washing with phosphatebuffered saline. Subsequently, mononuclear cells were isolated via Histopaque1077 (Sigma-Aldrich) centrifugation (pooled isolated cells of each animal group). Isolated cells were attached onto poly-L-lysine-coated slices, fixed with 4% (w/v) formalin, washed with phosphate-buffered saline, stained with MOMA-2 (a rat monoclonal antibody to the monocyte and macrophage marker; dilution, 1:25; 60 min; room temperature) and Alexa488 (an antirat monoclonal antibody; dilution, 1:200; 60 min; room temperature), and finally counterstained with Hoechst33258 dye (0.2 mg/mL, 10 min, 4°C). The cells were then imaged and analyzed via a confocal laser scanning microscope equipped with a laser diode (405 nm), an argon laser (458, 477, 488, and 514 nm), and 2 helium-neon lasers (543 and 633 nm).
RESULTS
What Is the Constitution of the FRET Probe?
The chosen dyes DY-682 (donor; absorption [abs]/ emission [em], 674/712 nm) and DY-782 (acceptor; abs/ em, 752/795 nm) display a significant spectral overlap between the donor emission and the acceptor absorption spectrum (Supplemental Fig. 1 ; supplemental materials are available online only at http://jnm.snmjournals.org) enabling efficient energy transfer. As a negative control, DY-505 (abs/em, 498/529 nm), displaying a fluorescence spectrum that has only little overlap with the absorption of DY-782, was used as the donor. This resulted in a low efficiency for energy transfer to DY-782. The chemical structures, spectroscopic properties, and FRET parameters of these fluorophores are summarized in Supplemental Figure 2 and in Table 1 . After coupling the dyes to polyclonal rabbit IgG molecules, a dye-to-protein ratio of between 2.9 and 3.1 was achieved.
Does FRET Occur When Probe Mixtures Are Adsorbed onto Western Blotting Membranes?
The results from fluorescence measurements with the probes DY-505, DY-682, and DY-782 alone or in combination, spotted onto adsorbing membranes (0.2 nmol of each dye, corresponding to 130 pmol/cm 2 ), are summarized in Figure 1 . This model system was used to provide a dye concentration that is sufficiently high to result in small dye-to-dye distances, thereby favoring FRET. The fluorescence intensity of the donor DY-682 strongly decreases in the presence of the acceptor DY-782, and simultaneously, the emission of the latter is enhanced when DY-682 is added (Fig. 1A, left) . For the control pair, no distinct influence of the presence of DY-505 on the signal derived from DY-782 could be detected, and vice versa (Fig. 1A,  right) . This finding was confirmed by semiquantitative analysis, in which each fluorescence signal represents the area under the curve of the respective unmixed spectrum. The emission of DY-782 is enhanced in the presence of DY-682, and simultaneously, the signal of DY-682 is diminished. The intensities of DY-505 and DY-782 are hardly affected when combined. Moreover, when the amounts of donor and acceptor are varied (constant donor-to-acceptor stoichiometry of 1 to 1), a distinct increase in acceptor fluorescence in the presence of the donor was observed at the highest amounts tested (0.2 nmol, corresponding to 130 pmol/cm 2 for each dye, Figs. 1B and 1C) , with a concomitant quenching of donor fluorescence. With a Förster radius of approximately 6 nm for DY-682, optimal donor-to-acceptor distances to result in FRET were achieved at amounts of 0.2 nmol (130 pmol/cm 2 for each dye, estimated donor-toacceptor distance of 4 nm). In contrast, this was not the case in relation to the DY-505-DY-782 couple. Given the (Fig. 1D) , FRET was also detectable but not for the control pair (IgG-DY-505 and IgG-DY-782). Interestingly, a distinct dependency on probe concentration and, concomitantly, on donor-to-acceptor distance was observed (Fig. 1D In a second step toward in vivo FRET imaging, we evaluated our IgG-conjugated dyes in vitro in cultivated J774 macrophage cells. The expected signaling of each of the donor and acceptor fluorophores alone or in the presence of its counterpart dye was observed after accumulation in endocytic and phagocytic cell compartments (Fig. 2) . Semiquantitative analysis of cell pellets incubated with both IgG-DY-682 and IgG-DY-782 revealed a distinct decrease in DY-682 fluorescence compared with that of IgG-DY-682 alone and an increase in the IgG-DY-782 signal. For the IgG-DY-505-IgG-DY-782 system, only a slight change in IgG-DY-505 fluorescence intensity and no change in IgG-DY-782 emission were observed. Comparable results were obtained when macrophages were analyzed after incubation with the native fluorophores of the FRET and control pair. These results suggest the occurrence of FRET in living biologic systems such as macrophages for the IgG-DY-682-IgG-DY-782 system. The close proximity of both probes in target cells was shown by confocal laser scanning microscopy of macrophages that had been incubated with the probes, unveiling internalization into cytoplasmatic compartments (supplemental data).
Does the Presence of Skin and Tissue Autofluorescence Affect Detectability of FRET In Vivo?
For the envisioned exploitation of FRET in vivo for the simultaneous imaging of multiple probe-target interactions, it is essential that these effects are detectable through the skin and are not superimposed or falsified by tissue autofluorescence. Therefore, as a next step, we embedded labeled macrophages (unstained macrophages, after incubation with donor probe or acceptor probe alone or with donor and acceptor probe) and injected them subcutaneously into the back of NMRI mice. As follows from Figure 3 and as observed in previous in vitro experiments, the signal of IgG-DY-682 is reduced in the presence of IgG-DY-782, and the fluorescence of IgG-DY-687 is enhanced for these locally accumulated cells in vivo. In the case of the IgG-DY-505-IgG-DY-782 pair, acceptor IgG-DY-782 fluorescence (caused by direct acceptor excitation) showed no distinct change in intensity regardless of the presence of DY-505 (Fig. 3 , bottom right). All data refer to a 30-min postinoculation time. These results were confirmed by semiquantitative analysis of fluorescence intensities (Supplemental Fig. 3 ). Subsequent to inoculation of the labeled cells, the IgG-DY-682 signal alone was compared several times with the IgG-DY-682 signal in the presence of DY-782 over a period of 24 h. In each case, a reduced signal was observed. Simultaneously, the emission of IgG-DY-782 increased, with the highest intensity occurring 2 h after inoculation. For the control pair, the donor IgG-DY-505 was not distinctly quenched in the presence of the acceptor probe IgG-DY-782. The IgG-DY-782 signal was initially high immediately after cell inoculation and remained almost unchanged in the presence or absence of the donor. Although the observed fluorescence intensities were generally lower than in the in vitro experiments, this in vivo model demonstrates that FRET could even be detected through the skin of living organisms.
Does FRET Take Place After Systemic Probe Application in an In Vivo Mouse Ear Edema Model?
FRET was observed to take place in vivo in an inflammation model: a zymosan A-induced ear edema model (Fig. 4) (21) . After injection of the probes (55 nmol per kilogram of body weight) either separately or in combination into edematous mice, the IgG-DY-682 fluorescence strongly decreased in the presence of IgG-DY-782 (Fig. 4 : DY-682 signal). Distinct IgG-DY-682-induced enhancement of the IgG-DY-782 emission (DY-782 signal) was observed up to 4 h after injection and became moderate after 6 h (Supplemental Fig. 4, semiquantitative analysis) . In the case of the IgG-DY-505-IgG DY-782 system, the emission of strongly suggest that FRET also occurs in vivo after systemic probe application. Analysis of isolated monocytes and macrophages in the area of the zymosan injection verified DY molecule uptake (Supplemental Fig. 6 ).
DISCUSSION
Nearly all pathophysiologic disease involves key activation processes represented by the interaction of two or more molecular species. In vivo image-based identification of such interactions should markedly foster the understanding of pathophysiologic processes, particularly in preclinical research activities. As revealed by our in vitro and in vivo spectral multiplexing approach, simple near-infrared targeted probes designed as a FRET pair are capable of cooperative signaling. This finding underlines the potential of this imaging strategy to unveil FIGURE 2. FRET effects can also be observed for DY-682 with DY-782 after internalization of dyes by murine macrophages J774. After incubation of J774 macrophages for 24 h with IgG-coupled dyes (1.2 nmol/ mL), cells were pelleted and imaged using whole-body NIRF imaging system. Semiquantitative analysis of fluorescence intensity was performed for each fluorophore alone (white bars) or in combination For the IgG-coupled fluorophores, the occurrence of FRET was detectable after direct application of the different probes spotted on a Western blotting membrane. In emission, spectral cross talk between donor and acceptor fluorescence can be excluded, as the emission profile of the acceptor (the IgG-DY-782) can be clearly discriminated from that of the donor via spectral analysis. The influence of the direct excitation of the acceptor was controlled by comparison of the fluorescence intensities obtained in the presence and absence of the donor. The influence of the distance between the donor and acceptor probe could be indirectly demonstrated by the fact that changes in FRET-related fluorescence were observed only at defined donor-acceptor concentrations (stoichiometry, 1 to 1). The fact that FRET was also observed after coupling of dye molecules to comparatively large IgGs is attributed to preferential dye binding to primary amino groups in the lysine-rich regions of the Fc domain of this molecule. Close proximity between donor and acceptor fluorophores was given by a distinct condensation of these Fc domains on Western blotting membranes and after probe internalization in endosomal compartments of phagocytes.
We showed that FRET can be detected when IgG-DY-682-IgG-DY-782 pairs are packed into phagocytotic compartments of macrophages as a result of the phagocytotic activity of these cells. This brings the differently labeled probes into close proximity as a result of intracytoplasmic condensation into endolysosomes/phagosomes (22) . The observed decrease of DY-682 fluorescence (compared with the respective chromophore alone) is a strong indication for energy transfer, thereby paralleling the results observed for probe mixtures on nitrocellulose membranes. The used chromophores are stable in the presence of a low pH and proteases (23) , suggesting they should survive in an acidic and enzymatic milieu of endolysosomes after cell internalization.
In a following step, when the probes were systemically applied in a mouse edema model, FRET was detectable as well. Here, the necessary close proximity between the dyes to enable FRET signaling in vivo is ensured using an inflammatory model, where phagocytes are recruited (24, 25) and lead to an internalization of the antibody-based probes via Fc receptors. Dye internalization could be confirmed by microscopic analysis.
Interestingly, after systemic probe application, distinct probe accumulation kinetics at the edematous region were found, as derived from a comparison of time-dependent signaling in animals carrying implanted (labeled) macrophages with macrophages of edematous regions. The continuous decrease in signaling of implanted macrophages was probably caused by continuous cell division (population doubling time of macrophage cell line, ;30 h [our own unpublished data]); migration of macrophages out of the edematous region (26) ; immune reactions against syngeneic but not allogenic cells, leading to their elimination; or a combination of these effects. In contrast, signaling after systemic probe application is mainly the result of continuous infiltration of the edematous region by phagocytes (27) , which were previously labeled as a consequence of the intravenous application of the conjugated antibodies (28) . It has been shown (29) that phagocytes are recruited from a splenic reservoir at the site of inflammation, implying that, in relation to the model used here, probes would be internalized by phagocytes on their way through circulation rather than at the inflammatory region itself.
Using the edema model, we have shown, for what is to our knowledge the first time, that FRET is possible when a contrast agent cocktail is administered into a nonengineered living organism. This is by far a simpler strategy than using systems in which chromophore-modified (fused) proteins are to be incorporated into cells in order to detect specific molecule interactions (7) (8) (9) 30, 31) . Even though this in vivo approach represents a proof of concept, labeling of macrophages via FRET is expected to work also in other disease models related to spontaneous inflammatory processes, such as rheumatoid arthritis. Specific cell internalization processes may be elucidated in future. Even though potential clinical applications remain to be elucidated, the use of near-infrared chromophores is advantageous because of good tissue penetration and improved signal-to-noise ratios (2,3), compared with approaches using luminescent or fluorescent proteins at shorter wavelengths. Accordingly, our data show that the occurrence of FRET is not falsified by tissue autofluorescence and is detectable through the skin.
One important aspect for in vivo intramolecular FRET, as shown here, is the need to apply donor and acceptor molecules with similar pharmacokinetics, allowing a reproducible stoichiometry between donor and acceptor probes at the target region. Here, this requirement was fulfilled, since the same antibody was used although with 2 different chromophores. Our proof of concept addressed also the functionality of probe internalization via macrophages. However, when more site-specific protein interactions are being addressed, the necessity to adjust the chemical constitution of the donor and acceptor molecules to the respective target might lead to varying pharmacokinetics and, consequently, to different stoichiometries. The result could be unfavorable conditions (e.g., in terms of donor-acceptor stoichiometry) under which FRET might be difficult to detect. Further challenges could arise in obtaining sufficient expression of target molecules and good accessibility to high-affinity probes so as to achieve reliable signaling in vivo.
The use of a whole-body multispectral imaging system in conjunction with spectral unmixing comprises a comparatively simple methodology for multiplexed biomarker analysis. In this context, the omission of a control system with the application of donor or acceptor probes per se would be advantageous. In contrast, the elucidation of structural components near each other cannot be obtained using conventional colocalization analysis of spectral signatures and superimposition of false color images, methods that have so far been used for in vivo imaging.
CONCLUSION
Our system-because it can be extended beyond the cellular processes shown here to molecular interactions via FRET signaling using target-specific probes-paves the way for new preclinical in vivo molecular imaging approaches. With respect to feasibility and gained advantages, in vivo near-infrared multiplexed imaging via FRET shows potential to become a new and robust tool for drug discovery and basic research in biomedicine.
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